By combining high-throughput immunosequencing of CSF B cell repertoires with in silico epitope prediction models and in vitro activation assays, we were able to identify idiotope-specific memory T cells expressing CCR6 in nine out of nine assessed MS patients. This evidence concerns the gene CCR6 and myeloid sarcoma.